Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|September 16, 2011
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumorsWiebke Arlt, Michael Biehl, Angela E Taylor, et al.Journal of the American College of Cardiology|December 13, 2006
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patientsGian Paolo Rossi, Giampaolo Bernini, Chiara Caliumi, et al.The Journal of Clinical Endocrinology and Metabolism|July 9, 2016
Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg MutationCristina L Ronchi, Guido Di Dalmazi, Simon Faillot, et al.The Journal of Clinical Endocrinology and Metabolism|September 8, 2005
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month studyGianluca Aimaretti, Maria Rosaria Ambrosio, Carolina Di Somma, et al.The New England Journal of Medicine|June 8, 2007
Adjuvant mitotane treatment for adrenocortical carcinomaMassimo Terzolo, Alberto Angeli, Martin Fassnacht, et al.The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.Endocrine|January 30, 2017
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient databaseFrancesca Giusti, Luisella Cianferotti, Francesca Boaretto, et al.Endocrine|July 23, 2018
Correction to: Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient databaseFrancesca Marini, Francesca Giusti, Caterina Fossi, et al.Endocrine|March 3, 2018
Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient databaseFrancesca Marini, Francesca Giusti, Caterina Fossi, et al.Nature Genetics|February 19, 2013
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertensionFelix Beuschlein, Sheerazed Boulkroun, Andrea Osswald, et al.Pageof 14